InvestorsHub Logo
Followers 53
Posts 9976
Boards Moderated 1
Alias Born 10/06/2005

Re: None

Friday, 08/13/2021 9:11:50 AM

Friday, August 13, 2021 9:11:50 AM

Post# of 9866
It's possible this is one of the new pharma deals mentioned in the Q2 report/ We have a relationship established i the plasma bus.

Grifols, S.A. subsidiary announces enrollment of first patient in Phase 1 trial of GIGA-2050 for COVID-19
10:28 AM ET 8/11/21 | Briefing.com
GigaGen, a subsidiary of Grifols, announced today the first patient has been dosed in its Phase 1 clinical trial of GIGA-2050, the company's recombinant hyperimmune polyclonal antibody drug designed to provide passive immunity to COVID-19 patients.GIGA-2050 is comprised of more than 12,000 antibodies demonstrating strong neutralizing activity against natural SARS CoV-2 variants in laboratory studies.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PAYS News